DiagnaMed Launches Innovative Brain Health AI
Company Announcements

DiagnaMed Launches Innovative Brain Health AI

DiagnaMed Holdings Corp. (TSE:DMED) has released an update.

DiagnaMed Holdings Corp. has partnered with Drexel University to introduce CERVAI™, a cutting-edge brain health AI platform designed to estimate brain age and assess cognitive health. By utilizing an EEG headset and machine-learning technology, CERVAI™ aims to identify early signs of cognitive decline, enabling timely interventions. The company is expanding its commercial pilot program across the US and Canada, targeting a variety of health and wellness clinics.

For further insights into TSE:DMED stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskDiagnaMed and EIREX Team Up for Hydrogen Innovation
TipRanks Canadian Auto-Generated NewsdeskDiagnaMed Holdings Announces Stock Options and Debt Settlement
TipRanks Canadian Auto-Generated NewsdeskDiagnaMed Advances Hydrogen Therapy for Brain Health
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App